×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PHGE – biomx inc. common stock (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PHGE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/21
07:00 am
phge
Microbiome Sequencing Services Business Report 2024-2030: Strong Investment in Genomics Research Crucial for Market Growth [Yahoo! Finance]
Medium
Report
Microbiome Sequencing Services Business Report 2024-2030: Strong Investment in Genomics Research Crucial for Market Growth [Yahoo! Finance]
11/20
11:07 am
phge
Converge Bio raises $5.5M Seed to speed up drug discovery and development with Generative AI [Yahoo! Finance]
Medium
Report
Converge Bio raises $5.5M Seed to speed up drug discovery and development with Generative AI [Yahoo! Finance]
11/15
02:22 am
phge
BiomX Inc (PHGE) Q3 2024 Earnings Call Highlights: Strong Net Income Amid Rising Expenses [Yahoo! Finance]
High
Report
BiomX Inc (PHGE) Q3 2024 Earnings Call Highlights: Strong Net Income Amid Rising Expenses [Yahoo! Finance]
11/14
06:47 am
phge
BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates [Yahoo! Finance]
High
Report
BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates [Yahoo! Finance]
11/14
06:30 am
phge
BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates
High
Report
BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates
11/12
12:20 pm
phge
BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024
Low
Report
BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024
10/15
08:43 am
phge
BiomX announces a mandatory unit separation [Seeking Alpha]
Neutral
Report
BiomX announces a mandatory unit separation [Seeking Alpha]
10/15
07:00 am
phge
BiomX Announces a Mandatory Unit Separation
Medium
Report
BiomX Announces a Mandatory Unit Separation
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
04:49 pm
phge
Form 10-Q BiomX Inc. For: Sep 30
High
Report
Form 10-Q BiomX Inc. For: Sep 30
11/14
06:46 am
phge
Form 8-K BiomX Inc. For: Nov 14
High
Report
Form 8-K BiomX Inc. For: Nov 14
11/13
05:31 pm
phge
Form SCHEDULE 13G BiomX Inc. Filed by: Nantahala Capital Management, LLC
Medium
Report
Form SCHEDULE 13G BiomX Inc. Filed by: Nantahala Capital Management, LLC
11/13
05:15 pm
phge
Form SC 13G/A BiomX Inc. Filed by: AMR Action Fund, L.P.
Medium
Report
Form SC 13G/A BiomX Inc. Filed by: AMR Action Fund, L.P.
11/4
04:06 pm
phge
Form SC 13G/A BiomX Inc. Filed by: Burbank John Howard III
Medium
Report
Form SC 13G/A BiomX Inc. Filed by: Burbank John Howard III
10/28
04:01 pm
phge
Form SC 13G/A BiomX Inc. Filed by: Centaurus Investments Ltd
Low
Report
Form SC 13G/A BiomX Inc. Filed by: Centaurus Investments Ltd
10/25
09:27 am
phge
Form 25-NSE BiomX Inc. Filed by: NYSE AMERICAN LLC
Medium
Report
Form 25-NSE BiomX Inc. Filed by: NYSE AMERICAN LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/19
Chardan Acts as M&A Advisor in Health Sciences Acquisitions Corporation Completed Merger with Immunovant
12.2%
12/30 Form 4 BiomX Inc. For: Dec 20 Filed by: GROSSMAN JONAS 10.8%
4/25 BiomX Inc. (NASDAQ: PHGE) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 7.5%
3/26 BiomX Reports Full Year 2019 Financial Results and Provides Business Update 7.4%
2/17 BiomX To Present Pre-clinical Data at the Plenary Session of the AACR Microbiome, Viruses, and Cancer Conference 3.9%
3/27 Form 4 BiomX Inc. For: Mar 25 Filed by: Wolfson Marina 3.1%
12/12 Form 4 BiomX Inc. For: Dec 10 Filed by: OrbiMed Israel GP Ltd. 2.3%
3/20 BiomX Discloses Acne Pre-clinical Data Planned for 2020 AAD Annual Meeting 2.2%
12/2 BiomX Announces Completion of Enrollment for Double-Blind, Placebo-Controlled Clinical Study of BX001 in Acne-Prone Skin 1.8%
1/15 Form 3 BiomX Inc. For: Jan 15 Filed by: Wolfson Marina 1.7%
12/30 Form 4 BiomX Inc. For: Dec 20 Filed by: GROSSMAN JONAS 10.8%
4/25 BiomX Inc. (NASDAQ: PHGE) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 7.5%
3/26 BiomX Reports Full Year 2019 Financial Results and Provides Business Update 7.4%
2/17 BiomX To Present Pre-clinical Data at the Plenary Session of the AACR Microbiome, Viruses, and Cancer Conference 3.9%
3/27 Form 4 BiomX Inc. For: Mar 25 Filed by: Wolfson Marina 3.1%
12/12 Form 4 BiomX Inc. For: Dec 10 Filed by: OrbiMed Israel GP Ltd. 2.3%
3/20 BiomX Discloses Acne Pre-clinical Data Planned for 2020 AAD Annual Meeting 2.2%
12/2 BiomX Announces Completion of Enrollment for Double-Blind, Placebo-Controlled Clinical Study of BX001 in Acne-Prone Skin 1.8%
1/15 Form 3 BiomX Inc. For: Jan 15 Filed by: Wolfson Marina 1.7%
TOP News Decliners
3/31
BiomX Announces Positive Topline Data from Phase 1 Study for Lead Candidate BX001 for Acne-Prone Skin
-9.3%
11/7 Form 3 BiomX Inc. For: Oct 28 Filed by: Woodman Robbie -8.3%
11/12 Form 3 BiomX Inc. For: Nov 04 Filed by: Sullivan Lynne Marie -5.7%
11/12 Stone Street Group Initiates Coverage On BiomX Inc. -5.5%
11/5 Form 3 BiomX Inc. For: Oct 28 Filed by: TAKEDA PHARMACEUTICAL CO LTD -3.9%
11/1 Form 8-K BiomX Inc. For: Oct 28 -3.2%
1/8 BiomX Inc. (NASDAQ: PHGE) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock. -3.2%
11/20 Form 4 BiomX Inc. For: Nov 18 Filed by: GROSSMAN JONAS -3.0%
2/3 BiomX Announces Dual Listing on the Tel-Aviv Stock Exchange -2.8%
11/4 BiomX Appoints Russell G. Greig, Ph.D, as Chairman of the Board of Directors and Lynne Sullivan as Board Director -2.8%
11/7 Form 3 BiomX Inc. For: Oct 28 Filed by: Woodman Robbie -8.3%
11/12 Form 3 BiomX Inc. For: Nov 04 Filed by: Sullivan Lynne Marie -5.7%
11/12 Stone Street Group Initiates Coverage On BiomX Inc. -5.5%
11/5 Form 3 BiomX Inc. For: Oct 28 Filed by: TAKEDA PHARMACEUTICAL CO LTD -3.9%
11/1 Form 8-K BiomX Inc. For: Oct 28 -3.2%
1/8 BiomX Inc. (NASDAQ: PHGE) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock. -3.2%
11/20 Form 4 BiomX Inc. For: Nov 18 Filed by: GROSSMAN JONAS -3.0%
2/3 BiomX Announces Dual Listing on the Tel-Aviv Stock Exchange -2.8%
11/4 BiomX Appoints Russell G. Greig, Ph.D, as Chairman of the Board of Directors and Lynne Sullivan as Board Director -2.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: